Skip to content
‹ Back to IndustriesSciences

Uncountable adds cleanroom monitoring with links from results to CAPA and batch records

Uncountable’s environmental monitoring module, launched Nov. 10, 2026, maps sampling points and can connect results to CAPA and batch records. The links matter most. EU GMP Annex 1 asks sterile manufacturers to trend results and keep reviewing a site control strategy, which takes connected records rather than a PDF, a spreadsheet and a phone.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By MarketScale Newsroom · UncountableEnvironmental MonitoringEu Gmp Annex 1Cleanroom Contamination Control
Share
Uncountable adds cleanroom monitoring with links from results to CAPA and batch records

Key takeaways

01

Proving a sample was taken is the easy part of an Annex 1 inspection; showing what the result means for the batch filled in that room depends on how monitoring records connect to CAPA, batch and training files.

02

Uncountable's module records whether a cleanroom was at rest or in operation for every sample, so results can be trended by room state, method and location instead of reviewed one excursion at a time.

03

Before buying any monitoring software, ask which linked records a site will actually populate, how the system behaves without connectivity, and how instrument telemetry gets in, since Uncountable does not ingest sensor data natively.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Most cleanroom monitoring programs live in three places: the floor plan in a PDF, the sampling schedule in a spreadsheet, the photos on a technician's phone. Julia Turner, product manager at Uncountable, named exactly that setup when the San Francisco software company launched an environmental monitoring capability on November 10, 2026, according to its Business Wire announcement. Her complaint was that every investigation starts by reconciling the three.

The module sits inside Uncountable's product development and quality platform, Contract Pharma's Charlie Sternberg reported, and is aimed at pharmaceutical and biotech manufacturers running classified cleanrooms. Food, beverage, cosmetics and specialty chemicals plants are on the target list too. The floor-plan map is the feature in the screenshots. The more consequential design choice is what happens to a result after the lab enters it.

That choice matters because the revised EU GMP Annex 1 expects sterile manufacturers to show more than a completed sampling calendar. Turner told Cleanroom Technology that quality teams can usually prove monitoring took place. Where they struggle is explaining what the data means for product risk, or how it connects to decisions made earlier in development.

From floor plan to lab request

Setup starts with an area. A team uploads the floor plan for a room or zone, say a sterile filling suite or a ready-to-eat packing zone, and classifies it by EU GMP grade A to D, ISO 14644-1 class 5, 7 or 8, or food hygienic zone 1 to 4. Sampling points go directly on that map, each with a code and a configured method such as swab, air sampling or settle plate. Uncountable's product page says a point can be dragged when a line moves, and its coordinates update on the record.

Next comes the sampling plan. The team selects points on the map, sets a daily, weekly, monthly or yearly frequency with start and end dates, and the platform calculates every event in that window. Each event generates a lab request and a sample for every selected point, with configurable reminders. One product screenshot shows a weekly plan producing 13 events across three points. For cleanroom samples, the record also notes whether the room was at rest or in operation.

In the field, technicians open the request on an approved mobile device or the web platform, enter sample data and attach photos taken at collection. The examples Uncountable gives are specific: an obstruction or a small shift in sampling position. A phone can also pair to an open desktop record by QR code. The photo lands on the sample record itself, which is the whole point of Turner's camera-roll complaint.

None of these steps is exotic. What changes is that location, grade, plan, room state and evidence are fields on one record instead of facts reassembled after an excursion. Every one of them becomes something a reviewer can filter on.

What Annex 1 asks of monitoring data

The revised Annex 1 was published August 25, 2022 and took effect August 25, 2023, with the lyophilizer sterilization requirement in point 8.123 following on August 25, 2024. Keith Lamb and John Darby of Lachman Consultants laid out its reach in a Contract Pharma feature: it applies to every sterile medicinal product licensed in the EU, wherever the plant sits, and the FDA helped draft it and trains its inspectors on it even though it is not binding on US products.

How far the revised Annex 1 reaches

58 pages
Length of the revised Annex 1, up from 16 in the 2008 version, so far more detail for inspectors to test
54 authorities
Health authorities in the PIC/S mutual recognition scheme, which adopted the Annex verbatim and includes the US FDA

Lachman Consultants via Contract Pharma

Turner's description of the monitoring burden is the useful part for software buyers. Annex 1, she told Cleanroom Technology, requires sites to justify sampling locations through risk assessment, trend results over time instead of only reacting to excursions, and show the site control strategy is reviewed and improved continuously. Trending is a query problem. A query only works if each result already carries its location, grade, plan and room state, and that is the data model Uncountable is selling.

The site control strategy is the documented, site-wide plan that environmental monitoring feeds into. Lamb and Darby advise that the strategy and the risk assessments behind it carry documented quality oversight, review and approval, because inspectors examine them first.

Results are checked against configurable specification limits, and out-of-spec values are flagged. From there a team can open a quality record in Uncountable's QMS that stays linked to the sample. Cleanroom Technology's report goes further than the press release: monitoring results can also connect to nonconformance and CAPA records and to the batches, materials, equipment and personnel training records for the affected area and time period.

That last list is where the product either earns its place or doesn't. After an out-of-limit plate, the investigator's real questions are which batches were filled, which operators were gowned in and which equipment was running in that room at that time. If those records share a data model with the result, the answer would be a lookup instead of a week of requests to other departments. Turner described the payoff as a single traceable chain from cleanroom to product that an inspector can follow.

Proving a plate was exposed is the easy part of an Annex 1 inspection; showing what that result means for the batch filled in the same room is where scattered records fail a quality team.

The compliance plumbing is what a regulated buyer would expect. Records carry audit logs and electronic signatures aligned to 21 CFR Part 11 and EU Annex 11, changes are archived rather than deleted, and GxP validation documentation supports the platform. Uncountable's AI agent, Bodie, sits on top. It can answer questions such as which locations have had repeated failed checks in the last 30 days, compare results by method, location and occupancy state, chart the trend for each sampling point and summarize attached lab reports. The product page says Bodie works under normal access checks when updating approved records.

The strongest objection comes from the Lachman authors themselves. They note that many manufacturers already had much of Annex 1 in place through years of CAPA and continuous improvement, and that the usual gap is systematic, documented, demonstrated compliance. Software can hold that documentation. It cannot do the risk assessment that justifies where the points go, and the batch and training links only help if a site actually populates them.

Where the platform hands off

Separation Science's Sharon Dong, drawing on Uncountable's product page, flagged two boundaries worth writing into any requirements document. Mobile capture needs connectivity. Sensor data is not ingested natively, so telemetry platforms connect through an integration. For sites whose monitoring includes continuous instrument feeds, that integration work belongs in the project scope from the start.

The same routes handle an existing LIMS: external systems connect through Uncountable's API, SDK or Model Context Protocol access, along with environmental, health and safety platforms. Uncountable, founded in 2016, already runs ELN, LIMS, QC LIMS, PLM and QMS on one structured data model, per its announcement, and says it is deployed by more than 200 enterprise product development teams. Rollout follows a staged sequence the company leads, from configuration through testing, go-live and hypercare.

The food-plant angle is more than a marketing footnote for multi-category manufacturers. The FDA's preventive controls rule requires environmental monitoring for certain ready-to-eat foods, and Dong points out that the written procedures under 21 CFR 117.165(b)(3) must name sampling locations and number of sites, timing and frequency, analytical methods, the testing lab, test microorganisms and corrective actions. Most of those map onto fields this module already holds, which could let a company running both hygienic zones and graded cleanrooms keep one monitoring model.

Questions to bring to the demo

For a quality director weighing this against a standalone monitoring system or the current spreadsheet, the evaluation comes down to the links, not the map. Three questions do most of the work:

  1. Pick a real excursion from the past year and ask the vendor to rebuild its trail live: point, room state, lab result, CAPA, then the batches and training records for that room and time window.
  2. Ask which linked records the site must populate itself, and which arrive automatically from the LIMS, batch or training systems already in place.
  3. Ask how sampling continues in a room with poor connectivity, and how telemetry from existing instruments reaches the record.

The signal worth watching is the first inspection where a pharma user walks an investigator from a flagged plate to the affected batch inside one system. The sources so far don't show how inspectors treat software-linked traceability as evidence for a site control strategy, and that first report will tell buyers more than any feature list.

Featured companies

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

MarketScale Newsroom
MarketScale NewsroomEditorial Team, MarketScale

The MarketScale Newsroom reports on the companies, technologies, and trends shaping 16 B2B industries. It turns primary sources and expert commentary into clear, useful coverage for the people doing the work.

B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

PharmaLogic buys Lantheus' New Jersey radiopharma plant with a supply deal attached

PharmaLogic buys Lantheus' New Jersey radiopharma plant with a supply deal attached

PharmaLogic is buying Lantheus' contract manufacturing unit and Springfield, New Jersey radiopharmaceutical plant, plus a long-term deal to make lutetium Lu 177 dotatate for Lantheus. Radioligand developers looking for capacity should ask how much of the plant's capacity is still open.

  • 01A long-term supply contract attached to a plant sale could help keep costly hot-cell capacity in use. According to Grand View Research, committed supply agreements are among the tools that help providers align capital spending with customer development milestones.
  • 02Radioligand developers evaluating PharmaLogic's Agilera unit should ask how much Springfield capacity the lutetium Lu 177 dotatate contract will take up and how much is left for new programs.
  • 03Two pending transactions shape what to watch next: regulatory review and closing conditions for the PharmaLogic purchase, and Curium’s August offer of upward of $8 billion for Lantheus, which is still closing.

Nov 18, 2026

Merck KGaA moves Rapid Micro’s Growth Direct from distribution to ownership for QC labs

Merck KGaA moves Rapid Micro’s Growth Direct from distribution to ownership for QC labs

Merck KGaA agreed to buy Rapid Micro Biosystems, maker of the Growth Direct microbial testing platform, for $0.75 per share in cash. The deal turns a 2025 distribution partnership into ownership. Growth Direct instruments, consumables and software would then come from the company that already sells QC products to pharma labs, pending a December 2026 close.

  • 01Growth Direct shifts from a Merck-distributed product, under a February 2025 agreement, to a Merck-owned one inside a QC portfolio that spans environmental monitoring, in-process and release testing.
  • 02For labs that already run Growth Direct alongside MilliporeSigma QC products, the useful question is how the platform's digital sample records will connect to the rest of that workflow after close.
  • 03The next date to watch is the Schedule TO filing that opens the tender offer; closing targeted for December 2026 requires a majority of Rapid Micro’s voting shares to be tendered.

Nov 17, 2026

SR-Tiget gene therapy families average six months in Milan, with years of follow-up testing

SR-Tiget gene therapy families average six months in Milan, with years of follow-up testing

Gene therapy at Milan’s SR-Tiget includes a family support programme that helps relatives manage months-long stays (often around six months) for treatment, while a regulated lab can track patient samples for up to 20 years. Follow-up visits can outnumber new treatments, adding to the long-term workload.

  • 01In 2025, the programme logged 133 follow-up visits against 17 treatments; with roughly 15 years of twice-yearly checkups per patient, the follow-up load is likely to keep growing even if new treatments stay flat.
  • 02At SR-Tiget, the average family spends six months in Milan, and the child's samples can keep reaching the lab for as long as twenty years.
  • 03A practical question for gene therapy services: who alerts the lab when a child’s fever delays a blood draw? At SR-Tiget, research nurses manage the patient schedule and coordinate sample timing with the lab.

Nov 16, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

MarketScale Newsroom
MarketScale Newsroom

Editorial Team

MarketScale

The MarketScale Newsroom reports on the companies, technologies, and trends shaping 16 B2B industries. It turns primary sources and expert commentary into clear, useful coverage for the people doing the work.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512